Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

被引:84
作者
Puurunen, Johanna [1 ,4 ,5 ]
Piltonen, Terhi [1 ,4 ,5 ]
Puukka, Katri [3 ,6 ]
Ruokonen, Aimo [3 ]
Savolainen, Markku J. [2 ,4 ,5 ,7 ]
Bloigu, Risto [8 ]
Morin-Papunen, Laure [1 ]
Tapanainen, Juha S. [1 ,4 ,5 ,9 ]
机构
[1] Univ Oulu, Inst Clin Med, Dept Obstet & Gynecol, FI-90014 Oulu, Finland
[2] Univ Oulu, Inst Clin Med, Dept Internal Med, FI-90014 Oulu, Finland
[3] Univ Oulu, Inst Diagnost, Dept Clin Chem, FI-90014 Oulu, Finland
[4] Oulu Univ Hosp, Clin Res Ctr, FI-90014 Oulu, Finland
[5] Oulu Univ Hosp, Med Res Ctr, FI-90014 Oulu, Finland
[6] Oulu Univ Hosp, NordLab Oulu, FI-90014 Oulu, Finland
[7] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland
[8] Univ Oulu, Med Informat & Stat Res Grp, FI-90014 Oulu, Finland
[9] Univ Helsinki, Dept Obstet & Gynecol, FI-00029 Helsinki, Finland
基金
芬兰科学院;
关键词
GLUCOSE-TOLERANCE; ATORVASTATIN; SIMVASTATIN; PREVALENCE; METFORMIN;
D O I
10.1210/jc.2013-2674
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Statins have been shown to improve hyperandrogenism in women with polycystic ovary syndrome (PCOS). However, their use has also been associated with impairment of glucose metabolism and an increased risk of type 2 diabetes mellitus. Because women with PCOS are prone to disturbances in glucose metabolism, statin therapy could also have negative effects. Objective: Our objective was to explore the effects of atorvastatin therapy on hormonal and metabolic parameters in women with PCOS. Design and Setting: We conducted a randomized, double-blind, placebo-controlled 6-month follow-up study conducted at Oulu University Hospital, Finland. Patients: Women with PCOS (Rotterdam criteria) were treated with atorvastatin (20 mg/d, n = 15) or placebo (n = 13) for 6 months. Interventions: Fasting serum samples were collected at baseline and at 3 and 6 months. Oral and iv glucose tolerance tests were performed at 0 and 6 months. Main Outcome Measures: Androgen secretion and glucose metabolism were measured. Results: Fasting levels and area under the curve of insulin increased significantly and insulin sensitivity (insulinogenic and Matsuda indexes) decreased during 6 months of atorvastatin therapy. Serum levels of dehydroepiandrosterone sulfate decreased in the atorvastatin group, whereas no change was observed in serum testosterone levels. Levels of C-reactive protein, total and low-density lipoprotein-cholesterol, and triglycerides decreased significantly during statin therapy. Conclusions: Atorvastatin therapy improves chronic inflammation and lipid profile, but it impairs insulin sensitivity in women with PCOS. Because women with PCOS have an increased risk of developing type 2 diabetes mellitus, the results suggest that statin therapy should be initiated on the basis of generally accepted criteria and individual risk assessment of cardiovascular disease, and not only because of PCOS.
引用
收藏
页码:4798 / 4807
页数:10
相关论文
共 36 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]  
Altman DG, 1991, PRACTICAL STAT MED R, P433
[4]   Translating the effects of statins: From redox regulation to suppression of vascular wall inflammation [J].
Antonopoulos, Alexios S. ;
Margaritis, Marios ;
Shirodaria, Cheerag ;
Antoniades, Charalambos .
THROMBOSIS AND HAEMOSTASIS, 2012, 108 (05) :840-848
[5]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[6]   Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: Prospective, randomized, crossover trial [J].
Banaszewska, Beata ;
Pawelczyk, Leszek ;
Spaczynski, Robert Z. ;
Dziura, James ;
Duleba, Antoni J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) :456-461
[7]   Effects of Simvastatin and Metformin on Polycystic Ovary Syndrome after Six Months of Treatment [J].
Banaszewska, Beata ;
Pawelczyk, Leszek ;
Spaczynski, Robert Z. ;
Duleba, Antoni J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (11) :3493-3501
[8]   TOWARD PHYSIOLOGICAL UNDERSTANDING OF GLUCOSE-TOLERANCE - MINIMAL-MODEL APPROACH [J].
BERGMAN, RN .
DIABETES, 1989, 38 (12) :1512-1527
[9]   EQUIVALENCE OF THE INSULIN SENSITIVITY INDEX IN MAN DERIVED BY THE MINIMAL MODEL METHOD AND THE EUGLYCEMIC GLUCOSE CLAMP [J].
BERGMAN, RN ;
PRAGER, R ;
VOLUND, A ;
OLEFSKY, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :790-800
[10]   Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial [J].
Duleba, AJ ;
Banaszewska, B ;
Spaczynski, RZ ;
Pawelczyk, L .
FERTILITY AND STERILITY, 2006, 85 (04) :996-1001